Wilder Ivana Wrobleski, Reskallah Alexander, Pivalizza Catherine M, Bynon John S, Pivalizza Evan G
Anesthesiology Institute, Cleveland Clinic Foundation, Cleveland, Ohio.
Department of Anesthesiology, Critical Care and Pain Medicine, MD Anderson Cancer Center, Houston, Texas.
Proc (Bayl Univ Med Cent). 2022 Oct 14;36(1):96-98. doi: 10.1080/08998280.2022.2126928. eCollection 2023.
Although thrombocytopenia is common in end-stage liver disease, severe, refractory thrombocytopenia during liver transplantation is rare, and if immune based, usually presents months or years later. This case describes an adult woman in whom preoperative evaluation had not determined an immune-related cause of thrombocytopenia. Clot strength was dramatically impaired as measured by thrombelastography during the transplant. Following a lack of response to repeat platelet transfusions, splenectomy was performed after graft reperfusion with rapid temporal restoration of clot strength. This case shows a severe manifestation of perioperative thrombocytopenia during liver transplantation and clinically guided management when measured clot strength is too low for accurate determination.
虽然血小板减少症在终末期肝病中很常见,但肝移植期间严重的难治性血小板减少症却很罕见,而且如果是免疫性的,通常在数月或数年后出现。本病例描述了一名成年女性,术前评估未确定血小板减少症的免疫相关病因。移植期间通过血栓弹力图测量发现凝血强度显著受损。在多次输注血小板无效后,在移植肝再灌注后进行了脾切除术,凝血强度迅速恢复。本病例显示了肝移植期间围手术期血小板减少症的严重表现,以及当测量的凝血强度过低无法准确判断时的临床指导管理。